We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$127B
1-Year Est. Return
44.11%
This Fund
S&P 500
This Quarter
Est. Return
+12.35%
1 Year Est. Return
+44.11%
3 Year Est. Return
+121.64%
5 Year Est. Return
+154.22%
10 Year Est. Return
+724.54%
AUM
$136B
AUM Growth
+$12.5B
(+10%)
Cap. Flow
-$1.5B
Cap. Flow
% of AUM
-1.11%
Top 10 Holdings %
Top 10 Hldgs %
28.12%
Holding
295
New
4
Increased
72
Reduced
149
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elanco Animal Health
ELAN
|
+$789M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$158M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$91.7M |
| 4 |
CVS Health
CVS
|
+$88.1M |
| 5 |
Novartis
NVS
|
+$86.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$896M |
| 2 |
NVIDIA
NVDA
|
+$256M |
| 3 |
Amgen
AMGN
|
+$155M |
| 4 |
Cisco
CSCO
|
+$138M |
| 5 |
Adobe
ADBE
|
+$131M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.33% |
| 2 | Healthcare | 24.5% |
| 3 | Industrials | 15.11% |
| 4 | Consumer Discretionary | 9.46% |
| 5 | Financials | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Revvity
RVTY
$12.8B
| $281M | 0.21% |
2,916,571
-172,840
| -6% | -$15.6M |
|
102
Textron
TXT
$15.4B
| $268M | 0.2% |
5,292,360
+116,746
| +2% | +$6.02M |
|
|
ELLI
103
DELISTED
Ellie Mae Inc
ELLI
| $268M | 0.2% |
2,711,045
-89,400
| -3% | -$7.76M |
|
|
EXAS
104
DELISTED
Exact Sciences
EXAS
| $259M | 0.19% |
2,989,200
-205,902
| -6% | -$17.5M |
|
105
Tesla
TSLA
$1.3T
| $256M | 0.19% |
13,701,225
-7,500
| -0.1% | -$151K |
|
106
Progressive
PGR
$125B
| $253M | 0.19% |
3,512,877
-550,000
| -14% | -$37.7M |
|
107
Linde
LIN
$226B
| $252M | 0.19% |
1,430,269
-1,100
| -0.1% | -$183K |
|
108
US Bancorp
USB
$99.6B
| $247M | 0.18% |
5,124,179
-1,300
| -0% | -$65.2K |
|
109
Xencor
XNCR
$1.55B
| $233M | 0.17% |
7,503,883
-109,100
| -1% | -$3.63M |
|
|
VMW
110
DELISTED
VMware, Inc
VMW
| $229M | 0.17% |
1,266,195
-47,700
| -4% | -$7.77M |
|
111
DXC Technology
DXC
$1.73B
| $220M | 0.16% |
3,425,108
-66,427
| -2% | -$4.25M |
|
|
PXD
112
DELISTED
Pioneer Natural Resource Co.
PXD
| $208M | 0.15% |
1,367,296
+649,746
| +91% | +$91.7M |
|
|
POLY
113
DELISTED
Plantronics, Inc.
POLY
| $207M | 0.15% |
4,485,550
| – | – |
|
114
EOG Resources
EOG
$70.7B
| $207M | 0.15% |
2,172,396
-700
| -0% | -$66.7K |
|
|
SFLY
115
DELISTED
Shutterfly, Inc.
SFLY
| $204M | 0.15% |
5,007,582
+131,300
| +3% | +$5.77M |
|
116
Applied Materials
AMAT
$428B
| $201M | 0.15% |
5,064,160
+70,550
| +1% | +$2.68M |
|
|
S
117
DELISTED
Sprint Corporation
S
| $196M | 0.14% |
34,760,400
-104,900
| -0.3% | -$650K |
|
118
Stratasys
SSYS
$774M
| $182M | 0.13% |
7,652,200
+5,711
| +0.1% | +$138K |
|
119
MarketAxess Holdings
MKTX
$5.72B
| $178M | 0.13% |
724,220
-56,000
| -7% | -$12.7M |
|
120
Comscore
SCOR
$109M
| $177M | 0.13% |
437,908
+5,631
| +1% | +$2.29M |
|
121
Entegris
ENTG
$23.2B
| $171M | 0.13% |
4,788,941
-700
| -0% | -$23.3K |
|
122
Raymond James Financial
RJF
$34B
| $164M | 0.12% |
3,059,925
+667,950
| +28% | +$35.8M |
|
123
Apple
AAPL
$4.57T
| $162M | 0.12% |
3,403,200
+122,800
| +4% | +$5.21M |
|
124
Descartes Systems
DSGX
$6.82B
| $161M | 0.12% |
4,413,000
| – | – |
|
125
TransDigm Group
TDG
$67.7B
| $154M | 0.11% |
340,244
+106,794
| +46% | +$43.3M |
|
Similar funds
VAM
Primecap Management's Q1 2019 Portfolio in Review
As of Q1 2019, Primecap Management held 295 positions worth $136B, up 10% from $123B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Trading was light in Q1 2019: portfolio turnover was 2%. Primecap Management opened 4 new positions and exited 2, leaving the 295-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Industrials.
- Primecap Management's largest Q1 2019 buy was Lyft: 500,000 shares worth $39.1M.
- Primecap Management added most to Elanco Animal Health in Q1 2019, an estimated $789M increase.
- Primecap Management's biggest Q1 2019 reduction was Eli Lilly, cutting an estimated $896M.
- Primecap Management fully exited MINDBODY, Inc. Class A Common Stock in Q1 2019, selling an estimated $5.84M.
- Primecap Management's ten largest holdings make up 28% of its $136B portfolio in Q1 2019.
- Primecap Management opened 4 new positions and closed 2 in Q1 2019.
- Primecap Management's portfolio value rose 10% quarter-over-quarter to $136B.
Based on Primecap Management's 13F filing for Q1 2019, filed 14 May 2019.